A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
Clinical trial NCT03929172 · COMPLETED
Trial details
- NCT number
- NCT03929172
- Sponsor
- 2A Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2020-05-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.